Nova Publishers
My Account Nova Publishers Shopping Cart
HomeBooksSeriesJournalsReference CollectionseBooksInformationSalesImprintsFor Authors
            
  Top » Catalog » Journals » Journal of Alternative Medicine Research » Volume 2 Issue 4 Articles » My Account  |  Cart Contents  |  Checkout   
Quick Find
  
Use keywords to find the product you are looking for.
Advanced Search
What's New? more
Theory of Literature
$270.00
Shopping Cart more
0 items
Information
Shipping & Returns
Privacy Notice
Conditions of Use
Contact Us
Bestsellers
01.Carrageenan (Chondrus Crispus): A Systematic Review by the Natural Standard Research Collaboration pp. 395-403
02.Black Seed (Nigella Sativa): A Systematic Review by the Natural Standard Research Collaboration pp. 385-394
Notifications more
NotificationsNotify me of updates to Carrageenan (Chondrus Crispus): A Systematic Review by the Natural Standard Research Collaboration pp. 395-403
Tell A Friend
 
Tell someone you know about this product.
Carrageenan (Chondrus Crispus): A Systematic Review by the Natural Standard Research Collaboration pp. 395-403 $45.00
Authors:  (Catherine Ulbricht, J. Kathryn Bryan, Dilys Burke, Julie Conquer, Dawn Costa, Nicole Giese, Richard Isaac, Idalia Rychlik, Erica Rusie, Minney Varghese, Wendy Weissner and Jen Woods)
Abstract:
Objective: To evaluate the scientific evidence on carrageenan including history, folkloric precedent, expert opinion, pharmacology, dosing, interactions, adverse effects, and toxicology. This review serves as a clinical support tool. Methods: Electronic searches were conducted in ten databases, 20 additional journals (not indexed in common databases), and bibliographies from 50 selected secondary references. No restrictions were placed on language or quality of publications. All literature collected pertained to efficacy in humans, dosing, precautions, adverse effects, use in pregnancy/lactation, interactions, alteration of laboratory assays, and mechanisms of action. Standardized inclusion/exclusion criteria are utilized for selection. Grades were assigned using an evidence-based grading rationale. Results: The review found that there was limited high-quality human evidence supporting the safety and effectiveness of carrageenan. The available human and non-human studies show possible effectiveness in anorectal lesions, anti-inflammatory, antimicrobial, antioxidant atherosclerosis, bladder disorders, bronchitis, cancer cough, demulcent, diabetes, diarrhea, food uses, gastrointestinal disorders, herpes simplex virus, high blood pressure, human papillomavirus immunomodulator, kidney disorders, laxative, obesity, rickets, sexually transmitted diseases (STDs), tuberculosis, ulcers. Conclusion: There is insufficient available evidence regarding the efficacy of carrageenan; the quality of the studies is low and the magnitude of the effect of carrageenan tends to be small. Regarding safety, carrageenan may be harmful in those with cardiovascular, endocrine, gastrointestinal, genitourinary, hematologic, and immunologic conditions. Larger, randomized, placebo controlled, double-blinded clinical trials with nonbiased sponsors are warranted in order to confirm the safety and efficacy of carrageenan as an integrative therapy. 


Available Options:
Version:
Special Focus Titles
01.Violent Communication and Bullying in Early Childhood Education
02.Cultural Considerations in Intervention with Women and Children Exposed to Intimate Partner Violence
03.Chronic Disease and Disability: The Pediatric Lung
04.Fruit and Vegetable Consumption and Health: New Research
05.Fire and the Sword: Understanding the Impact and Challenge of Organized Islamism. Volume 2

Nova Science Publishers
© Copyright 2004 - 2020

Carrageenan (Chondrus Crispus): A Systematic Review by the Natural Standard Research Collaboration pp. 395-403